Compare ZETA & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZETA | BCPC |
|---|---|---|
| Founded | 2007 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.8B |
| IPO Year | 2021 | N/A |
| Metric | ZETA | BCPC |
|---|---|---|
| Price | $18.31 | $157.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | $26.25 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 5.0M | 238.0K |
| Earning Date | 11-04-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | N/A | ★ 22.48 |
| EPS | N/A | ★ 4.57 |
| Revenue | ★ $1,224,703,000.00 | $1,013,548,000.00 |
| Revenue This Year | $30.55 | $10.52 |
| Revenue Next Year | $30.24 | $5.69 |
| P/E Ratio | ★ N/A | $34.21 |
| Revenue Growth | ★ 35.87 | 7.55 |
| 52 Week Low | $10.69 | $139.17 |
| 52 Week High | $26.60 | $177.40 |
| Indicator | ZETA | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 55.00 |
| Support Level | $17.24 | $155.46 |
| Resistance Level | $19.96 | $161.23 |
| Average True Range (ATR) | 0.77 | 4.10 |
| MACD | -0.05 | 0.46 |
| Stochastic Oscillator | 39.34 | 72.35 |
Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.